---
schema_version: "secwatch.filing_event.v1"
accession: "0001645113-25-000045"
form_type: "8-K"
ticker: "NVCR"
cik: "0001645113"
company_name: "NovoCure Ltd"
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:53:11.611595+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Novocure appoints President Frank Leonard as CEO; Ashley Cordova resigns

## Summary
- Ashley Cordova resigned as CEO and director effective Nov 30, 2025; no disagreement related to operations.
- Frank Leonard, previously President, becomes CEO effective Dec 1, 2025; he joined Novocure in 2010.
- Cordova enters garden leave through May 31, 2026, with salary, benefits, bonus, and CHF 375,000 cash payment.
- Leonard led global business operations since Jan 2024 and prior innovation/product development.
- Executive Chairman William Doyle cites Leonard as ideal for upcoming transformative milestones.

## SEC filing metadata
- accession: 0001645113-25-000045
- form_type: 8-K
- ticker: NVCR
- cik: 0001645113
- company_name: NovoCure Ltd
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645113/000164511325000045/0001645113-25-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645113/000164511325000045/nvcr-20251124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001645113-25-000045
- JSON: https://secwatch.observer/filing/0001645113-25-000045.json
- Plain text: https://secwatch.observer/filing/0001645113-25-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.